Adaptive Biotechnologies Corp - 8-K Filing
Adaptive Biotechnologies reports Q2 revenue of $71.6M with MRD growth up 33% YoY and raises full-year guidance (Items: 2.02 Results of Operations and Financial Condition, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)
Tickers: $ADPT